Pall and Artesyn Biosolutions team to industrialize single-use tech

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/scyther5)
(Image: Getty/scyther5)
Pall Corporation and Artesyn Biosolutions will co-develop clinical to commercial-scale solutions for single-use automated bioprocessing systems.

The strategic collaboration is between Pall’s biotech business unit and Artesyn Biosolutions, a manufacturer of single-use components and fluid management technologies.

"Our long-standing relationship with Artesyn that has now been formalized as a collaboration to combine and leverage our technologies to deliver industrial and modular single-use bioprocess solutions,"​ said Helene Pora, VP technical communication and regulatory strategy at Pall.

Together, Pora said the companies will be able to deliver automated single-use solutions to accelerate the speed of implementation and time to market for customers.

"And ultimately, this collaboration takes another step forward in industrializing the single-use industry,"​ she told us.

The partnership also advances Pall Biotech's expansion of its Allegro single-use solution portfolio from upstream through downstream and to final filling, according to the company.

Related news

Show more

Related product

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

Related suppliers

Follow us

Products

View more

Webinars